Equities

Benchmark Holdings PLC

Benchmark Holdings PLC

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (GBX)63.00
  • Today's Change0.50 / 0.80%
  • Shares traded155.56k
  • 1 Year change+16.67%
  • Beta1.0334
Data delayed at least 20 minutes, as of Nov 29 2021 16:27 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Monday, Benchmark Holdings PLC (BMK:LSE) closed at 63.00, -7.35% below its 52-week high of 68.00, set on Apr 19, 2021.
52-week range
Today
51.20Nov 27 202068.00Apr 19 2021
Markit short selling activity
Low
Med
High
Open62.00
High64.00
Low62.00
Bid52.00
Offer72.00
Previous close63.00
Average volume67.29k
Shares outstanding670.38m
Free float514.46m
P/E (TTM)--
Market cap423.26m GBP
EPS (TTM)-0.0122
GBP
Data delayed at least 20 minutes, as of Nov 29 2021 16:27 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on Benchmark Holdings PLC shares was Hold at 63.90 on 29 Nov 2021Read the full article
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.